Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Southern California
With
National Cancer Institute (NCI)
PRIMARY OBJECTIVES:
I. Examine the feasibility (acceptance among University of Southern California \[USC\] Norris study team members and Twitter users in Los Angeles \[LA\] county) of targeted social media listening (SML) via Twitter as a tool for enhancing recruitment to cancer trials.
II. Gain preliminary data on the impact (i.e., numbers recruited versus projected accrual compared to historic recruitment) of targeted social media listening (SML) as a tool for enhancing recruitment to cancer trials among Twitter users in LA county.
III. Estimate the effect size of the number of people enrolled associated with the use of targeted social media listening (SML) via Twitter as a tool for enhancing recruitment to cancer trials.
OUTLINE:
Patients who mention specific cancer disease keywords and/or hashtags are identified and receive a message via Twitter. Patients are then contacted for recruitment into a clinical trial.
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
TRIAL INCLUSION:
Focus on one of the following disease categories: non-small cell lung cancer, colon cancer, breast cancer, prostate cancer, kidney cancer, lymphoma
Be a phase 1 trial in expansion, phase 2, or 3
Be interventional trials
Recruit in English
Be Institutional Review Board (IRB)-approved and open to accrual at USC Norris
Recruit for at least 9 months at the point of enrollment
Set monthly accrual target \>= 1/ and annual accrual target \>= 12
PATIENT INCLUSION:
Will include all prospective trial participants in this study that come from Twitter in response of our SM recruitment interventions, provided they meet the specific trial's eligibility criteria
You may not be if
TRIAL EXCLUSION:
Phase 1 trials in dose escalation
PATIENT EXCLUSION:
Persons who do not meet the eligibility criteria of any of the trials open to accrual will be excluded from participation, and persons who may be eligible (e.g., disease/histology, stage, prior treatment) but do not meet additional trial-specific requirements such as insurance or allergy to drug)
Clareo Health | Social Media Listening in Improving Clinical Trial Recruitment in Patients With Cancer
